Bullish
Intel Stock Issuance Scale Surges 33% to $20B Amid $100B Institutional Demand
10:06
Intel expanded share offering from $15B to $20B with issue price at $95. GF Securities maintains $136 target, citing foundry break-even in late 2027 and strong EMIB client growth.
Woofun AI reports that Intel increased its stock issuance scale from the initially planned $15 billion to $20 billion, with institutional demand reportedly exceeding $100 billion. The issue price is set at $95, and all over-allotment options have been exercised. CEO Lip-Bu Tan and his family subscribed for approximately $12 million at the issue price.
GF Securities Overseas Electronics Newsletter reiterated its buy rating for Intel with a target price of $136, noting that the stock issuance sends positive signals. The report expects Intel's foundry business to reach break-even in the fourth quarter of 2027, with leverage effects on profit margins becoming fully evident in 2028. Intel raised expected earnings per share for 2026 and 2027 by 3% and 1%, respectively. The report estimates 18A chip yields will reach around 80% in the second quarter of 2026, while CWF enters capacity expansion. Back-end revenue forecasts for fiscal years 2027 and 2028 were raised to $1.1 billion and $7 billion, driven by AWS Trainium3 adopting EMIB-T in 2027 and Google's Humufish and Triggerfish chips expanding production from the second half of 2027 through 2028.
WOOFUN AI
Impact Assessment · Quick Read
The expansion of Intel's capital raise to $20 billion signals aggressive funding for its foundry turnaround, potentially alleviating near-term cash flow constraints for CapEx. Strong institutional oversubscription suggests market confidence in the execution of the 18A process and EMIB technology adoption by major hyperscalers like Apple, AWS, and Google. However, the reliance on 2027-2028 break-even timelines introduces execution risk if yield improvements or client ramp-ups lag behind schedule.
Generated by WOOFUN AI · For reference only, not investment advice
Comments
No comments yet.